What’s behind the injectable peptide craze?
from Full Story Hosted by The Guardian
Grey-market injectable peptides – a category of substances with obscure, alphanumeric names such as BPC-157, GHK-Cu and TB-500 – have developed a devoted following among biohackers and health optimisers. To understand how these unregulated substances have become mainstream and what they could be doing in our bodies, Madeleine Finlay hears from journalist Adrienne Matei and from Dr Anna Barnard, an associate professor at Imperial College London who researches peptides
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Full Story?
This episode is 18 minutes long.
When was this Full Story episode published?
This episode was published on April 5, 2026.
Can I download this Full Story episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.